Public Profile

bioMerieux

bioMérieux, a global leader in in vitro diagnostics, is headquartered in the United Kingdom and operates extensively across Europe, North America, and Asia. Founded in 1963, the company has established itself as a pioneer in microbiological testing and infectious disease diagnostics, achieving significant milestones in the development of innovative solutions. Specialising in the fields of clinical diagnostics, industrial microbiology, and food safety, bioMérieux offers a range of unique products and services, including automated systems and rapid testing kits. Their commitment to advancing healthcare through cutting-edge technology has positioned them as a trusted partner in laboratories worldwide. With a strong market presence and a reputation for excellence, bioMérieux continues to lead the way in improving patient outcomes and ensuring public health safety.

DitchCarbon Score

How does bioMerieux's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

3

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

6

Industry Benchmark

bioMerieux's score of 3 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.

62%

bioMerieux's reported carbon emissions

bioMérieux, headquartered in Great Britain, currently does not have publicly available carbon emissions data for the most recent year. As a result, specific figures regarding their Scope 1, 2, or 3 emissions are not provided. However, the company is committed to addressing climate change through various initiatives, although no specific reduction targets or climate pledges have been disclosed. In the absence of detailed emissions data, it is essential to note that bioMérieux is part of an industry increasingly focused on sustainability and reducing carbon footprints. As the company continues to develop its climate strategy, stakeholders can anticipate future commitments and initiatives aimed at enhancing environmental performance and reducing overall carbon emissions.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. bioMerieux's primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. bioMerieux is headquartered in GB, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

bioMerieux is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Health Services

Mr. Antonio Parente Duena

ES
Health Services
Updated 11 days ago

SPL Lifesciences

KR
Health Services
Updated 11 days ago

Nutrakey

CN
Health Services
Updated 11 days ago

SANAQ AG

CH
Health Services
Updated 11 days ago

NAVI NATURE

US
Health Services
Updated 11 days ago

Tsnn

BE
Health Services
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers